Parra-Izquierdo V, Otero-Regino W, Juliao-Banos F, Frias-Ordonez J, Ibanez-Pinilla E, Gil-Parada F
Crohns Colitis 360. 2025; 7(1):otae081.
PMID: 39834355
PMC: 11744193.
DOI: 10.1093/crocol/otae081.
Nguyen H, Fritzler M, Swain M
Front Mol Med. 2024; 2:914505.
PMID: 39086971
PMC: 11285550.
DOI: 10.3389/fmmed.2022.914505.
Hamsho S, Hariri M, Sleiay B, Daher Alhussen A, Sleiay M
JGH Open. 2024; 8(3):e13043.
PMID: 38444633
PMC: 10910874.
DOI: 10.1002/jgh3.13043.
Alsakarneh S, Duong N
Proc (Bayl Univ Med Cent). 2023; 36(6):705.
PMID: 37829232
PMC: 10566426.
DOI: 10.1080/08998280.2023.2257104.
Hatami B, Mosala M, Hassani A, Ehsani Ardakani M, Gholami S, Zali M
Pharmacol Res Perspect. 2022; 10(4):e00984.
PMID: 35822553
PMC: 9277608.
DOI: 10.1002/prp2.984.
Stent versus Balloon Dilation for the Treatment of Dominant Strictures in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis.
Ferreira M, Ribeiro I, Hourneaux de Moura D, McCarty T, da Ponte Neto A, Farias G
Clin Endosc. 2021; 54(6):833-842.
PMID: 34192839
PMC: 8652153.
DOI: 10.5946/ce.2021.052.
Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist.
Malik A, Kardashian A, Zakharia K, Bowlus C, Tabibian J
Liver Res. 2020; 3(2):118-127.
PMID: 32042471
PMC: 7008979.
DOI: 10.1016/j.livres.2019.04.001.
Large-duct cholangiopathies: aetiology, diagnosis and treatment.
Menon S, Holt A
Frontline Gastroenterol. 2019; 10(3):284-291.
PMID: 31288256
PMC: 6583582.
DOI: 10.1136/flgastro-2018-101098.
Comprehensive Review of Molecular Mechanisms during Cholestatic Liver Injury and Cholangiocarcinoma.
Virani S, Akers A, Stephenson K, Smith S, Kennedy L, Alpini G
J Liver. 2019; 7(3).
PMID: 30613437
PMC: 6319937.
DOI: 10.4172/2167-0889.1000231.
Primary sclerosing cholangitis: A review and update.
Tabibian J, Bowlus C
Liver Res. 2018; 1(4):221-230.
PMID: 29977644
PMC: 6028044.
DOI: 10.1016/j.livres.2017.12.002.
Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do?.
Malakouti M, Kataria A, Ali S, Schenker S
J Clin Transl Hepatol. 2017; 5(4):394-403.
PMID: 29226106
PMC: 5719197.
DOI: 10.14218/JCTH.2017.00027.
Primary sclerosing cholangitis: diagnostic and management challenges.
Sirpal S, Chandok N
Clin Exp Gastroenterol. 2017; 10:265-273.
PMID: 29138587
PMC: 5680897.
DOI: 10.2147/CEG.S105872.
Primary sclerosing cholangitis associated with severe ulcerative colitis in a young man.
Xavier Junior J, Coelho K, Sassaki L, Yamashiro F, Oliveira K, Marchesan Rodrigues M
Autops Case Rep. 2017; 3(4):37-41.
PMID: 28584805
PMC: 5453659.
DOI: 10.4322/acr.2013.037.
Biliary-duodenal anastomosis using magnetic compression following massive resection of small intestine due to strangulated ileus after living donor liver transplantation: a case report.
Saito R, Tahara H, Shimizu S, Ohira M, Ide K, Ishiyama K
Surg Case Rep. 2017; 3(1):73.
PMID: 28547740
PMC: 5445037.
DOI: 10.1186/s40792-017-0349-4.
Risk and Surveillance of Cancers in Primary Biliary Tract Disease.
Hrad V, Abebe Y, Ali S, Velgersdyk J, Al Hallak M, Imam M
Gastroenterol Res Pract. 2016; 2016:3432640.
PMID: 27413366
PMC: 4930812.
DOI: 10.1155/2016/3432640.
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).
Banales J, Cardinale V, Carpino G, Marzioni M, Andersen J, Invernizzi P
Nat Rev Gastroenterol Hepatol. 2016; 13(5):261-80.
PMID: 27095655
DOI: 10.1038/nrgastro.2016.51.
Cholangiocarcinoma Secondary to Primary Sclerosing Cholangitis in Explanted Livers: A Single-Center Study in the South of Iran.
Geramizadeh B, Ghavvas R, Kazemi K, Shamsaeefar A, Nikeghbalian S, Malekhosseini S
Hepat Mon. 2016; 15(12):e33626.
PMID: 26977169
PMC: 4779251.
DOI: 10.5812/hepatmon.33626.
Controversies in the management of primary sclerosing cholangitis.
Nayagam J, Pereira S, Devlin J, Harrison P, Joshi D
World J Hepatol. 2016; 8(5):265-72.
PMID: 26925200
PMC: 4757649.
DOI: 10.4254/wjh.v8.i5.265.
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.
Bernuzzi F, Marabita F, Lleo A, Carbone M, Mirolo M, Marzioni M
Clin Exp Immunol. 2016; 185(1):61-71.
PMID: 26864161
PMC: 4908296.
DOI: 10.1111/cei.12776.
A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis.
Zhu G, Shi K, Huang G, Wang L, Lin Y, Braddock M
Oncotarget. 2015; 6(29):26757-69.
PMID: 26378046
PMC: 4694950.
DOI: 10.18632/oncotarget.5610.
